Reynolds Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-2,800
Closed -$455K 115
2015
Q4
$455K Buy
2,800
+1,300
+87% +$204K 0.49% 58
2015
Q3
$207K Sell
1,500
-900
-38% -$142K 0.26% 126
2015
Q2
$368K Sell
2,400
-1,900
-44% -$304K 0.36% 101
2015
Q1
$687K Hold
4,300
0.6% 40
2014
Q4
$685K Sell
4,300
-600
-12% -$93.5K 0.57% 40
2014
Q3
$688K Buy
4,900
+1,600
+48% +$209K 0.67% 36
2014
Q2
$391K Sell
3,300
-500
-13% -$57.9K 0.26% 131
2014
Q1
$469K Buy
3,800
+400
+12% +$48.5K 0.3% 99
2013
Q4
$388K Buy
3,400
+500
+17% +$56.9K 0.22% 170
2013
Q3
$325K Buy
+2,900
New +$314K 0.21% 182

Other funds holding AMGN

Reynolds Capital Management's AMGN Position: Q1 2016 in Review

Reynolds Capital Management sold out of Amgen (AMGN) in Q1 2016, closing a stake of 2,800 shares — an estimated $455K sold.

Reynolds Capital Management first reported a position in AMGN in Q3 2013 and held it in 10 quarters. The position peaked at $688K in Q3 2014. 1,435 funds tracked by Wall St. Rank hold AMGN as of Q1 2016.

  • Reynolds Capital Management reported no remaining Amgen position as of Q1 2016 after selling out during the quarter.
  • Reynolds Capital Management sold 2,800 Amgen shares in Q1 2016, an estimated $455K.
  • Reynolds Capital Management first reported a position in Amgen in Q3 2013 and held it in 10 quarters.
  • Reynolds Capital Management's Amgen position peaked at $688K in Q3 2014.
  • 1,435 funds tracked by Wall St. Rank held Amgen as of Q1 2016.

Based on Reynolds Capital Management's 13F filing for Q1 2016, filed 13 May 2016.